Member Exclusive News

New model mimics patents’ response to current chemotherapy regimens

A novel in vitro model has been developed, which mimics the chemoresistance seen in mantle cell lymphoma patients after about 3 years of treatment. This work could help improve clinical outcomes for patients of the most aggressive form of non-Hodgkin’s lymphoma.

Go to the profile of Zoe Campbell
Aug 13, 2019

Please sign in or register for FREE

No comments yet.